Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Ron proto-oncogene product is a phenotypic marker of renal oncocytoma.

The American journal of surgical pathology - 1 Jun 2003

Rampino Teresa, Gregorini Marilena, Soccio Grazia, Maggio Milena, Rosso Renato, Malvezzi Paolo, Collesi Chiara, Dal Canton Antonio

Abstract excerpt

The proto-oncogene product Ron is the receptor for macrophage stimulating protein, a scatter factor that stimulates cell proliferation, prevents apoptosis, and induces an invasive cell phenotype. We investigated the expression of Ron, Ki-67 (proliferation index), p53, and bcl-2 (proapoptotic and antiapoptotic proteins, respectively) in 50 renal tumors (19 clear cell carcinomas, 18 oncocytomas, 7 papillary cell...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Kidney Neoplasms
Share to Adenoma, Oxyphilic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Apoptosis

Share to Hepatocyte Growth Factor

Share to Immunohistochemistry

Share to Protein Precursors

Share to Proto-Oncogene Mas

Share to Proto-Oncogene Proteins

Source

Identifiers

PMID: 12766581
DOI: 10.1097/00000478-200306000-00008

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Ron proto-oncogene product is a phenotypic marker of renal oncocytoma.PMID 12766581Read ↗

Update on classification of oncocytic neoplasms of the kidney.Semantic proximity Read ↗

Oncogenesis of RON receptor tyrosine kinase: a molecular target for malignant epithelial cancers.Semantic proximity Read ↗

Renal Cell Neoplasms of Oncocytosis Have Distinct Morphologic, Immunohistochemical, and Cytogenetic ProfilesSemantic proximity Read ↗

Frequent KRAS mutations in oncocytic papillary renal neoplasm with inverted nuclei.Semantic proximity Read ↗

Clear cell-papillary renal cell carcinoma of the kidney not associated with end-stage renal disease: clinicopathologic correlation with expanded immunophenotypic and molecular characterization of a large cohort with emphasis on relationship with renal angiomyoadenomatous tumor.Semantic proximity Read ↗

Point mutations and overexpression of Ron induce transformation, tumor formation, and metastasis.Semantic proximity Read ↗

Identification of the <i>ron</i> Gene Product as the Receptor for the Human Macrophage Stimulating ProteinSemantic proximity Read ↗

STK/RON receptor tyrosine kinase mediates both apoptotic and growth signals via the multifunctional docking site conserved among the HGF receptor family.Semantic proximity Read ↗

The RON and MET oncogenes are co-expressed in human ovarian carcinomas and cooperate in activating invasivenessSemantic proximity Read ↗

Restricted expression of the ron gene encoding the macrophage stimulating protein receptor during mouse developmentSemantic proximity Read ↗

Point mutations in the tyrosine kinase domain release the oncogenic and metastatic potential of the Ron receptor.Semantic proximity Read ↗

Nucleostemin mRNA is expressed in both normal and malignant renal tissuesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.